A bill to require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Read twice and referred to the Committee on Finance.
Email me when S 5797 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 5797. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the Secretary of Health and Human Services to create a pilot program aimed at expanding the use of biosimilar biological products for Medicare beneficiaries. It seeks to improve patient access and potentially lower drug costs. The measure is currently referred to the Senate Finance Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 5797
3 free questions a day, no accountSponsors
- Sen. Bennet, Michael F. [D-CO] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 5797 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 5797 freeOr ask your AI assistant about S 5797 directly:
Add to Claude, ChatGPT or Cursor